Red Wave Investments’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,254
Closed -$230K 99
2022
Q3
$230K Buy
5,254
+260
+5% +$12.6K 0.1% 83
2022
Q2
$262K Sell
4,994
-130
-3% -$6.63K 0.11% 84
2022
Q1
$265K Buy
5,124
+1,288
+34% +$66.8K 0.09% 86
2021
Q4
$227K Buy
+3,836
New +$190K 0.08% 94

Other funds holding PFE

Red Wave Investments's PFE Position: Q4 2022 in Review

Red Wave Investments sold out of Pfizer (PFE) in Q4 2022, closing a stake of 5,254 shares — an estimated $230K sold.

Red Wave Investments first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $265K in Q1 2022. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

  • Red Wave Investments reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
  • Red Wave Investments sold 5,254 Pfizer shares in Q4 2022, an estimated $230K.
  • Red Wave Investments first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
  • Red Wave Investments's Pfizer position peaked at $265K in Q1 2022.
  • 3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Red Wave Investments's 13F filing for Q4 2022, filed 3 Feb 2023.